Uwe Schoenbeck, Ph.D.
Chief Scientific Officer
External Science & Innovation (ES&I)
Senior Vice President, Pfizer Worldwide R&D
Chief Scientific Officer Uwe Schoenbeck leads Pfizer’s External Science & Innovation (ES&I) team, part of Worldwide R&D, which seeks to build a premier integrated external portfolio and innovative sourcing group to access and progress the best science from academic institutions, industry and biotechs. This global team identifies and establishes partnerships to gain first access to cutting edge science, innovative disease targets, drug candidates as well as platform technologies, from exploratory to clinical proof of concept and covers both small and large molecule approaches together with gene and cell therapies. ES&I maintains an in-depth network into key scientific global hubs through a science liaison model serving not only the needs of the Pfizer research units and R&D strategic priorities, but open to emerging and innovative ideas harvested from its targeted exploration centers, incubators, seed funds and investments vehicles.
Prior to joining Pfizer in 2009, Uwe was Vice President, External R&D Innovation for Wyeth Pharmaceuticals and was a member of the Wyeth’s R&D Executive Committee where he was responsible for developing and implementing Wyeth’s External R&D strategy and operations. Preceding his time at Wyeth Uwe served as the Vice President, Cardiovascular Research for Boehringer Ingelheim in Ridgefield, CT, and was responsible for the global cardiovascular research strategy and drug discovery program from target identification to Pre-Development including life cycle management for marketed and advanced pipeline products. Prior to joining Boehringer in 2003, he held the position of Assistant Professor of Medicine, Brigham & Women’s Hospital, Harvard Medical School.
Uwe received his degree from the University of Kiel, Germany, and completed postdoctoral training in the Division of Cardiovascular Medicine, Brigham & Women’s Hospital, Harvard Medical School, before joining as a faculty member. Uwe has served as a reviewer for multiple peer-reviewed journals (incl. Circulation, Circulation Research, Journal of Clinical Investigation, Journal of Experimental Medicine, Journal of Immunology, Journal of the American College of Cardiology (JACC), Nature Medicine, and the Proceedings of National Academy of Sciences U.S.A.) and has published more than 100 peer-reviewed articles, review articles/book chapters and abstracts with particular contributions in areas such as molecular & cell biology, cardiovascular research, immunology and metabolism.